LUCAT1 is a critical DDR regulator in GSCs under hypoxia and a promising target to enhance the efficacy of DDR inhibitors and radiotherapy in GBM.
Share your take
Add a clinician perspective alongside expert commentary.
Huang et al. (Sat,) studied this question.